I-Tofacitinib CAS:477600-75-2 Umkhiqizi Supplier
I-Tofacitinib iyisidakamizwa sokwelapha i-rheumatoid arthritis (RA), i-psoriasis, isifo samathumbu esivuvukalayo, nezinye izifo ze-immunological, kanye nokuvimbela ukwenqatshwa kokufakelwa kwezitho zomzimba.Kuyi-inhibitor ye-enzyme i-Janus kinase 3 (JAK3), okusho ukuthi iphazamisa indlela yokusayina ye-JAK-STAT edlulisela ulwazi ngaphandle kweseli ku-nucleus yeseli, okunomthelela ekulotshweni kwe-DNA.Muva nje kuboniswe kumodeli we-murine we-arthritis esungulwe, isifo se-tofacitinib esithuthukisiwe ngokushesha ngokuvimbela ukukhiqizwa kwabalamuleli abavuthayo kanye nokucindezela izakhi zofuzo ezincike ku-STAT1 ezicutshini ezihlangene. izindlela, okuphakamisa ukuthi i-tofacitinib ingase isebenzise inzuzo yokwelapha ngezindlela ezingagcini nje ngokuvinjelwa kwe-JAK3.
Ukwakheka | I-C16H20N6O |
Isivivinyo | 99% |
Ukubukeka | Impushana emhlophe |
Inombolo ye-CAS. | 477600-75-2 |
Ukupakisha | 25KG |
I-Shelf Life | iminyaka engu-2 |
Isitoreji | Gcina endaweni epholile neyomile |
Isitifiketi | ISO. |